BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

April to June 2007

Syngene Appoints New US Distributors and Sales Manager To Provide Superior Service and Support for US Customers

ReaX™ Custom Bead Service used for a novel field-based DNA security marking

Merck Deploys ArisGlobal’s Register™ Globally

Cellexus Biosystems plc appoints IUL as its exclusive distributor in Austria, Benelux Germany, the Netherlands and Switzerland

OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO OCEAN RIDGE BIOSCIENCES FOR MICROARRAY SERVICES

NiKem Research Srl Enters Into Research Service Agreement with InterMune, Inc.

Genetic Tests for Thrombotic Disease Could Save Lives and Reduce Healthcare Costs

Celogos Awarded ‘Médaille de la Ville’ for Contribution to Paris Economy

LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation

LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation

Amsterdam Molecular Therapeutics announces pricing of Initial Public Offering (IPO) on Euronext Amsterdam

Cellexus Biosystems plc appoints Appropriate Technical Resources Inc. as US Distributor

BioInvent implements a directed new share issue worth SEK 125 million and summons to an extraordinary shareholders' meeting

SANTARIS Hanne Damgaard Jensen appointed as SVP Product Development at Santaris Pharma

Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics

GATC strengthens management team with appointment of Dr Marcus Benz as Chief Operating Officer

INTEGRAGEN BECOMES FIRST CERTIFIED FRENCH SERVICE PROVIDER FOR ILLUMINA GOLDENGATE AND INFINIUM GENOTYPING

Pronota strengthens commercial team with appointment of Business Development Directo

New flu vaccine from PepTcell could provide immunity against all strains of influenza virus

Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene

TransPharma Medical Receives Second Milestone Payment from Teva Pharmaceutical Industries

World Leading Cardiologists Join BSP's Scientific Advisory Board

OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO AUSHON BIOSYSTEMS

Johnson & Johnson Selects ArisGlobal as its Global Pharmacovigilance and Safety Partner

IDBS announces the release of E-WorkBook Suite 7.0

New Feature in 2D Protein Gel Analysis Software Improves Confidence and Productivity in Proteomics Research

Clinical Data's Cogenics Division Launches Services on Roche 454 GS FLX

Forbion Announces Successful Exit from Alantos Pharmaceuticals

Amsterdam Molecular Therapeutics announces launch of Initial Public Offering (IPO) on Euronext Amsterdam

Faust Pharmaceuticals Present Phase IIa Results for Parkinson's Disease

Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemia

Research centre Jülich and ibidi launch in vivo-like cell cultivation on soft surfaces

Protagen expands Supervisory Board to support the development and commercialisation of its protein biochips

Thermo Fisher Scientific Introduces Revolutionary Device for Effective, Long-Lasting Prevention of Waterborne Contamination

Thrombotargets Corp. and Chemotargets to collaborate on identification of novel hits related with cardiovascular diseases

Thrombotargets Corp. Announces the Membership of Its New Scientific Advisory Board

AUSTRIANOVA completes first closing of 35 M EURO Series B financing

Diatos announces positive Phase I results for DTS-201 Doxorubicin prodrug program

Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology

BPI’s International Impact Honored by PRECARN

deltaDOT Ltd and Integrated Technologies receive £465k Grant from South East England Development Agency to develop Osprey, a decisive new tool in drug discovery

AMT Receives Orphan Drug Designation from FDA for AMT 011 for the Treatment of Lipoprotein Lipase Deficiency

OXFORD BIOMEDICA AND SANOFI-AVENTIS REPORT NEW TROVAX PHASE II TRIAL RESULTS IN RENAL CANCER

BRANE DISCOVERY ACQUIRES ORL-1 PROGRAM FROM NIKEM RESEARCH

Isogenica Enters into Research and License Agreement with Wyeth

Thermo Fisher Scientific Launches New Stackable Shaker

Cobra awarded DTI Grant to develop Cobra's oral vaccine delivery platform

AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy

LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro

Free pharmaceutical industry innovation and patent expiration metrics for media outlets

InferMed appoints new CEO

Thermo Fisher Scientific Announces New General Purpose Centrifuge System

Navigate the Fluorescent Minefield with a Free Poster on the "Spectra of Fluorescent Dyes" from Olympus

Mr. Gilles Brisson to join Cytomics Systems’ Supervisory Board

BioInvent updates project portfolio

Pronota strengthens board with appointment of Chairman

Dr Flemming Ørnskov appointed Chairman of Santaris Pharma Board

Q Chip launches the ReaXT 'Lab-in-a-Bead' technology - taking the mystery out of PCR

Arrayjet and BioMicro Systems partner in the USA

Arrayjet Launches Peerless Benchtop Inkjet Microarray Spotter for R&D Market

Amsterdam Molecular Therapeutics announces intention to launch an Initial Public Offering (IPO) on Euronext Amsterdam

Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study

MIP Technologies and Supelco Launch a New Selective SPE Product for Analysis of Tobacco-Specific Nitrosamines

TTP LABTECH'S MOSQUITO PROVIDES A UNIQUE APPROACH TO HANGING DROP AUTOMATION

PHASE II RESULTS FOR OXFORD BIOMEDICA'S HI-8 MEL IN MELANOMA TO BE PRESENTED AT AAI MEETING

Intelligent Design Makes Automated Chemistry Affordable

Protagen and ZAP partner with Kangdi Antibody Biotech and Bejing Proteome Research Centre to develop antibodies

Cellexus Biosystems plc launches the CellMaker Lite2TM – the latest generation of its novel disposable bioreactor

Agilent Technologies’ Mass Spectrometer with HPLC Chip Proves Winning Combo for New Blue Stream Laboratories Facility

Agilent Technologies Launches New Inductively Coupled Mass Spectrometer Delivering Higher Productivity, More Accurate Results

Agilent Technologies Receives the 2006 Frost & Sullivan Growth Strategy Leadership Award

Lectus Therapeutics wins ERBI's Innovation in Drug Discovery and Development Award

LifeCycle Pharma Receives US Patent for its MeltDose® Technology

Studies present compelling data on the p16(INK4a) biomarker at the 16th International Congress of Cytology

New High Resolution Image Analyser - Generates Excellent Results with Qdot Labelled Western Blots

Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral BelerofonR, its long-lasting, Interferon-alpha drug

Olympus Introduces FV1000 Multi-Laser Combiner System - Revolutionary multi-laser source!

New Species Named After Thermo Fisher Scientific: Fissuroderes thermoi

Targeted Genetics initiates phase I trial for childhood blindness

Angioblast cleared to trial stem-cell therapy for heart attack patients

Trexima has demonstrated consistent pain-free results across multiple migraine attacks

Array BioPharma initiates clinical trials of cancer drug

Additional indication for Pfizer's Fragmin

Dr Reddy's: Indian generic Rituxan launch flashes warning to biologics industry

Magnisense Appoints Business Developer for US Diagnostics Market

IDBS announces strategic partnership to improve presence and reach of Professional Services in German-speaking regions

Forbion Capital Partners adds top tier investors to its investor base

Astech Projects Launch the Astech Automation Challenge

ILLUMINA INFINIUM BEADCHIPS SELECTED BY GERMANY'S NATIONAL GENOME RESEARCH NETWORK TO SUPPORT ONE OF THE WORLD'S LARGEST GENETIC DISEASE STUDIES TO DATE

Thrombotargets Corp. and Specs achieve milestone in their Drug Discovery collaboration and announce the beginning of a new Anticoagulant program.

Thrombotargets inaugurates new facilities at the National Biotechnology Centre (CNB) in Madrid, Spain

Thrombotargets Corporation relocates to Research Triangle Park in North Carolina

Thrombotargets Corporation and Instituto Biomar to collaborate on identification and optimization of new drug candidates

Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Procoagulant Agent, TT-103MH, in the Treatment of Bleeding Episodes in Hemophiliacs

Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles

BAC ANNOUNCES COLLABORATION WITH SANOFI PASTEUR FOR VACCINE PURIFICATION

LifeCycle Pharma signs exclusive license agreement with Sciele Pharma to market a new formulation of fenofibrate in 120mg and 40mg dosage strengths

GATC Biotech demonstrates new DNA sequencing capability and sequences 9 bacterial genomes in April

ProtAffin AG secures Series A financing

Growing medical jobs careersite partners with GeneEd to offer online CME and CE courses

BioAlliance Pharma presents at BIO 2007

Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent

MIP Technologies and Supelco launch a new selective SPE product for the simultaneous extraction of beta agonists and antagonists

BioAlliance Pharma Announces Consolidated Revenues for Q1 2007

Nautilus Biotech closes €8.4 million ($11.3 million) investment funding

Lab21 announces appointment of new Chief Financial Officer

Biota announces A$16m quarterly royalties from Relenza antiviral

Protagen launches GMP protein analysis services

BioAlliance Pharma Announces Participation in Paris SmallCap Event April 26-27

APPLICATIONS OPEN FOR BURSARIES FOR BSR 2007

BRANE DISCOVERY LAUNCHED AS SPIN OUT OF R&D PROGRAMMES FROM NIKEM RESEARCH

Bridgehead International wins The Queen’s Award for Enterprise

Titian's Mosaic sample management software rapidly becoming industry standard

The latest in screening data management with ActivityBase XE v7.0

LANI completes Phase I in Japan and to commence Phase I in UK

Gene Bridges and BASF sign collaboration agreement

Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research

Agilent Technologies First Comprehensive Microarray System for Expression Profiling of Human miRNAs

Agilent Technologies Announces Belfast Winner of its Largest Ever European Promotional Prize

New CellReporter live cell based assay system from Genetix

Thermo Fisher Scientific Introduces Four Advanced Enhancements for its High Content Screening Platform

CAMBRIDGE ANTIBODY TECHNOLOGY AND PHILOCHEM ANNOUNCE TECHNOLOGY EVALUATION AGREEMENT

LibraGen Launches its First Family of Active Products Obtained by Enzymatic Transformation of Natural Substances

BioInvent Interim Report 1 January–31 March 2007

Hybrigenics' Inecalcitol Shows High Level of Tolerance

Thermo Fisher Scientific Introduces New -86°C Freezers

EU Commission issues a major communication on biotechnology - the Biotech industry responds

Novosom AG acquires exclusive option for CD40-targeted antisense inhibitors from Isis Pharmaceuticals

TTP LABTECH EXTENDS GLOBAL REACH Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia New Zealand

Dymension 2D Gel Analysis Software installed at Specialist University

Biacore to host DiPIA 2007 conference in Phoenix, Arizona May 6-9, Pointe Hilton Squaw Peak Resort

More Rapid Than Expected Type 2 Diabetes Incidence Will Drive Diagnostics and Therapeutics Market to $33 Billion by 2016

Affimed Closes € 25 million (US $ 32 million) Series B financing

Cytheris Names CFO and CMO as Company Boosts Clinical Development Program in Europe and the US

BPI Announces First Sales of Next-Generation TISSUEscope ™

BAC AND GE HEALTHCARE ANNOUNCE FVIII PURIFICATION MEDIA COLLABORATION

Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon®, its long-lasting, Interferon-alpha drug

Bt maize crops delivering health, wealth and environmental benefits in Europe


January to March 2008 Biotechnology News

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive


Site Map - new news site

Site Map - old news site

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.